Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Santos David A had 874 Rigel Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Santos David A (EVP, Chief Commercial Officer) had 874 Rigel Pharmaceuticals, Inc. shares withheld for tax at US$47.50 for US$41,515, leaving 61,622 shares. Filed Sep 3, 2026 (Form 4).
- Withheld for tax
- 874 shares
- Price
- US$47.50
- Value
- US$41,515
- Holding after
- 61,622 shares
- Trading plan
- No
- Role
- EVP, Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Shares withheld for tax | 874 | US$47.50 | 61,622 | Direct |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Santos David A
- Rigel Pharmaceuticals, Inc. shareholders
- Form 4 · Santos David A · Jun 3, 2026
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026